UVE shareholder trust (NYSE: UVE) plans sale of 25,000 common shares
Rhea-AI Filing Summary
A shareholder identified as the Stephen Donaghy Trust has filed a Form 144 notice relating to common shares of UVE. The filing covers an intended sale of 25,000 common shares through Wells Fargo Clearing Services on the NYSE around 12/30/2025, with an aggregate market value of
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for UVE disclose?
The Form 144 discloses that the Stephen Donaghy Trust intends to sell 25,000 common shares of UVE and provides details about the size, timing, and method of the planned sale.
How many UVE shares is the Stephen Donaghy Trust planning to sell?
The filing states that the Stephen Donaghy Trust plans to sell 25,000 common shares of UVE.
What is the aggregate market value of the UVE shares referenced in the Form 144?
The Form 144 lists an aggregate market value of
When and how did the Stephen Donaghy Trust acquire the UVE shares to be sold?
The 25,000 UVE common shares were acquired on 11/15/2018 in an open market purchase, with the purchase price paid in cash on that date.
What recent UVE share sales by the Stephen Donaghy Trust are reported?
The filing reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025, generating gross proceeds of
Which broker and exchange are involved in the planned UVE share sale?
The planned sale of 25,000 UVE common shares is listed as being through Wells Fargo Clearing Services on the NYSE.
What assurance does the seller give about information on UVE?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about UVE’s current or prospective operations that has not been publicly disclosed.